These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 38919485)
1. Prognostic models for mucinous and non-specific adeno cholangiocarcinoma: a population-based retrospective study. Azhar MS; Zhang ZJ; Liu ZT; Huang YP; Wang YX; Zhou H; Xiong L; Wen Y; Zou H Front Endocrinol (Lausanne); 2024; 15():1284283. PubMed ID: 38919485 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of web-based nomograms for predicting survival status in patients with intrahepatic cholangiocarcinoma depending on the surgical status: a SEER database analysis. Liu YG; Jiang ST; Zhang JW; Zhang L; Zhao HT; Sang XT; Lu X; Xu YY Sci Rep; 2024 Jan; 14(1):1568. PubMed ID: 38238494 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological features, prognostic factors, and prognostic survival prediction in patients with extrahepatic bile duct cancer liver metastasis. Huang X; Chen W; Liu J; Liao Y; Cai J; Zhong D Eur J Gastroenterol Hepatol; 2024 Aug; 36(8):1029-1037. PubMed ID: 38829959 [TBL] [Abstract][Full Text] [Related]
4. CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study. Jiao CY; Zhang H; Ji GW; Xu Q; Lu M; Zhang B; Yang Y; Wang XH; Li XC Eur Radiol; 2022 Dec; 32(12):8326-8338. PubMed ID: 35708837 [TBL] [Abstract][Full Text] [Related]
5. Primary tumor resection improves survival in patients with multifocal intrahepatic cholangiocarcinoma based on a population study. Yin L; Zhao S; Zhu H; Ji G; Zhang X Sci Rep; 2021 Jun; 11(1):12166. PubMed ID: 34108604 [TBL] [Abstract][Full Text] [Related]
6. Unveiling the unexplored secret: Aggressive behavior and poor survival in intrahepatic mucinous adenocarcinoma compared to conventional adenocarcinoma. Wang W; Lin H; Lu Q; Cai Y Biosci Trends; 2024 Sep; 18(4):370-378. PubMed ID: 39198179 [TBL] [Abstract][Full Text] [Related]
7. Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis. Zhang JX; Li P; Chen Z; Lin H; Cai Z; Liao W; Pan Z BMC Cancer; 2020 Jun; 20(1):556. PubMed ID: 32539768 [TBL] [Abstract][Full Text] [Related]
8. Survival Benefits of Postoperative Chemotherapy in Patients With Colorectal Mucinous Adenocarcinoma: An Analysis Utilizing Propensity Score Matching From the Surveillance, Epidemiology, and End Results Database. Rong J; Deng W Am Surg; 2024 Nov; 90(11):2969-2984. PubMed ID: 38849300 [TBL] [Abstract][Full Text] [Related]
9. Predictors of Distant Metastasis and Prognosis in Newly Diagnosed T1 Intrahepatic Cholangiocarcinoma. Guo K; Lou Y; Zheng S Biomed Res Int; 2023; 2023():6638755. PubMed ID: 36704724 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features, treatment, survival, and prognostic factors of combined hepatocellular and cholangiocarcinoma: A nomogram development based on SEER database and validation in multicenter study. Zhou YW; Li QF; Chen YY; Wang K; Pu D; Chen XR; Li CH; Jiang L; Wang Y; Li Q; Yang Y; Gou HF; Bi F; Liu JY; Chen Y; Qiu M Eur J Surg Oncol; 2022 Jul; 48(7):1559-1566. PubMed ID: 35115213 [TBL] [Abstract][Full Text] [Related]
11. Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery. He C; Zhang Y; Cai Z; Lin X BMC Cancer; 2019 Feb; 19(1):178. PubMed ID: 30813928 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic nomograms for newly diagnosed intrahepatic cholangiocarcinoma with brain metastasis: A population-based analysis. Liu Z; Yi J; Yang J; Zhang X; Wang L; Liu S Exp Biol Med (Maywood); 2022 Sep; 247(18):1657-1669. PubMed ID: 35946168 [TBL] [Abstract][Full Text] [Related]
13. The Integrated Prediction of Clinical and Pathological Factors on the Prognosis of Intrahepatic Cholangiocarcinoma. Chen G; Li S; Xia A; Xing Y; Liang W Am Surg; 2024 Jun; 90(6):1481-1490. PubMed ID: 38549438 [TBL] [Abstract][Full Text] [Related]
14. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis. Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642 [TBL] [Abstract][Full Text] [Related]
15. Prognostic model for oversurvival and tumor-specific survival prediction in patients with advanced extrahepatic cholangiocarcinoma: a population-based analysis. Zhang Y; Qiao C; Zhao P; Zhang C BMC Gastroenterol; 2023 Nov; 23(1):422. PubMed ID: 38036949 [TBL] [Abstract][Full Text] [Related]
16. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer. Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609 [TBL] [Abstract][Full Text] [Related]
17. [A novel nomogram for individualized preoperative prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma]. Ma WH; Lei ZQ; Yu QS; Xiao QR; Tang HL; Si AF; Yang PH; Cheng ZJ Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):363-371. PubMed ID: 35272428 [No Abstract] [Full Text] [Related]
18. Development and validation of a nomogram to predict cancer-specific survival with unresected cholangiocarcinoma undergoing external radiotherapy. Song J; Di Y; Kang X; Ren G; Wang Y Front Public Health; 2023; 11():1012069. PubMed ID: 36817916 [TBL] [Abstract][Full Text] [Related]
19. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis. Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787 [No Abstract] [Full Text] [Related]
20. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study. Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]